Literature DB >> 22553990

Gene-specific requirement of RNA polymerase II CTD phosphorylation.

Julie Drogat1, Damien Hermand.   

Abstract

The largest subunit of RNA polymerase II, Rpb1, contains an unusual C-terminal domain (CTD) composed of numerous repeats of the YSPTSPS consensus sequence. This sequence is the target of post-translational modifications such as phosphorylation, glycosylation, methylation and transitions between stereoisomeric states, resulting in a vast combinatorial potential referred to as the CTD code. In order to gain insight into the biological significance of this code, several studies recently reported the genome-wide distribution of some of these modified polymerases and associated factors in either fission yeast (Schizosaccharomyces pombe) or budding yeast (Saccharomyces cerevisiae). The resulting occupancy maps reveal that a general RNA polymerase II transcription complex exists and undergoes uniform transitions from initiation to elongation to termination. Nevertheless, CTD phosphorylation dynamics result in a gene-specific effect on mRNA expression. In this review, we focus on the gene-specific requirement of CTD phosphorylation and discuss in more detail the case of serine 2 phosphorylation (S2P) within the CTD, a modification that is dispensable for general transcription in fission yeast but strongly affects transcription reprogramming and cell differentiation in response to environmental cues. The recent discovery of Cdk12 as a genuine CTD S2 kinase and its requirement for gene-specific expression are discussed in the wider context of metazoa.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22553990     DOI: 10.1111/j.1365-2958.2012.08071.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  21 in total

1.  Distinct requirement of RNA polymerase II CTD phosphorylations in budding and fission yeast.

Authors:  Clément Cassart; Julie Drogat; Valérie Migeot; Damien Hermand
Journal:  Transcription       Date:  2012-09-01

2.  The calculation of transcript flux ratios reveals single regulatory mechanisms capable of activation and repression.

Authors:  Eric A Galburt
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-21       Impact factor: 11.205

Review 3.  Transcriptional control of HIV latency: cellular signaling pathways, epigenetics, happenstance and the hope for a cure.

Authors:  Uri Mbonye; Jonathan Karn
Journal:  Virology       Date:  2014-02-22       Impact factor: 3.616

Review 4.  Basic mechanisms of RNA polymerase II activity and alteration of gene expression in Saccharomyces cerevisiae.

Authors:  Craig D Kaplan
Journal:  Biochim Biophys Acta       Date:  2012-09-26

Review 5.  Prolyl isomerases in gene transcription.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-10-31

Review 6.  Post-transcriptional regulation of DNA damage-responsive gene expression.

Authors:  Bruce C McKay
Journal:  Antioxid Redox Signal       Date:  2013-09-12       Impact factor: 8.401

7.  Fission yeast Cdk7 controls gene expression through both its CAK and C-terminal domain kinase activities.

Authors:  Maxime Devos; Elise Mommaerts; Valerie Migeot; Harm van Bakel; Damien Hermand
Journal:  Mol Cell Biol       Date:  2015-02-17       Impact factor: 4.272

Review 8.  The Ess1 prolyl isomerase: traffic cop of the RNA polymerase II transcription cycle.

Authors:  Steven D Hanes
Journal:  Biochim Biophys Acta       Date:  2014-02-12

9.  Threonine-4 of the budding yeast RNAP II CTD couples transcription with Htz1-mediated chromatin remodeling.

Authors:  Emanuel Rosonina; Nathan Yurko; Wencheng Li; Mainul Hoque; Bin Tian; James L Manley
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-28       Impact factor: 11.205

Review 10.  Inhibitors of cyclin-dependent kinases as cancer therapeutics.

Authors:  Steven R Whittaker; Aurélie Mallinger; Paul Workman; Paul A Clarke
Journal:  Pharmacol Ther       Date:  2017-02-05       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.